Tsumura & Co. (OTCMKTS:TSMRF – Get Free Report) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 381,950 shares, an increase of 58.5% from the August 15th total of 240,989 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.
Tsumura & Co. Price Performance
Shares of Tsumura & Co. stock remained flat at $23.20 on Thursday. The business’s 50-day simple moving average is $23.20 and its 200-day simple moving average is $23.20. Tsumura & Co. has a 1-year low of $23.20 and a 1-year high of $25.75.
About Tsumura & Co.
Tsumura & Co is a Tokyo‐based pharmaceutical company specializing in the research, development and manufacture of Kampo medicines, which are traditional Japanese herbal remedies rooted in Chinese materia medica. The company’s core business revolves around the extraction, standardization and quality control of crude herbal ingredients, transforming them into prescription‐grade and over‐the‐counter products that are approved under Japan’s national health insurance system.
Leveraging a combination of modern analytical technology and traditional knowledge, Tsumura produces a broad portfolio of Kampo formulations for a range of therapeutic applications, including gastrointestinal health, circulatory support and immune regulation.
See Also
- Five stocks we like better than Tsumura & Co.
- CoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale
- Micron’s New 512GB Memory Module Deepens Its AI Infrastructure Advantage
- Banc of California Bets on Short-Term Pain
- Enterprise AI to Boost Broadcom’s Software Business? What Industry Data Shows
Receive News & Ratings for Tsumura & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tsumura & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
